US Patent Issued to CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH on July 29 for "MLL1 inhibitors and anti-cancer agents" (Chinese, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,434, issued on July 29, was assigned to CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH Co. LTD. (Shanghai).

"MLL1 inhibitors and anti-cancer agents" was invented by Zhenting Gao (Shanghai), Haibing Guo (Shanghai), Ming Li (Shanghai), Kun Chin Liu (Shanghai), Chunliang Lu (Shanghai), Zhuming Sun (Shanghai) and Yihui Zhu (Warren, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising s...